Levophacetoperane

Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate.

Levophacetoperane
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19NO2
Molar mass233.31 g/mol g·mol−1
3D model (JSmol)
  (verify)

See also

References
  1. Joseph Nicole Marie; Jacob Robert Michel (15 March 1960). "Patent US 2928835 - New esters". Rhône-Poulenc.
  2. Delbeke, F. T.; Debackere, M. (26 March 1975). "Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping". Journal of Chromatography A. 106 (2): 412–417. doi:10.1016/S0021-9673(00)93853-6. PMID 239015 – via ScienceDirect.
  3. Eric Konofal; Bruno Figadere (5 February 2015). "Patent Application US 20150038533 - Phacetoperane for the treatment of attention-deficit hyperactivity disorder". Assistance Publique – Hôpitaux de Paris.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.